These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1603159)

  • 1. [Immunotherapy in sepsis syndrome].
    Schellekens JF; van Deventer SJ
    Ned Tijdschr Geneeskd; 1992 May; 136(22):1050-4. PubMed ID: 1603159
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of septic shock with immunotherapy.
    Smith AL
    Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy of sepsis and septic shock].
    Ivanović D; Gjurasin M; Gasparović V; Radonić R; Kvarantan M; Merkler M
    Lijec Vjesn; 1995 Jun; 117 Suppl 2():8-11. PubMed ID: 8649167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytokines and septic shock. New perspectives on its treatment].
    Zamora Madaria E
    An Med Interna; 1993 Dec; 10(12):573-5. PubMed ID: 8049320
    [No Abstract]   [Full Text] [Related]  

  • 5. The physiologic basis for anticytokine clinical trials in the treatment of sepsis.
    Cain BS; Meldrum DR; Harken AH; McIntyre RC
    J Am Coll Surg; 1998 Mar; 186(3):337-50. PubMed ID: 9510266
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytokine inhibitors in intensive care].
    Villard J; Jolliet P; Chevrolet JC
    Rev Mal Respir; 1995; 12(4):335-42. PubMed ID: 7481045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Not just cachectin involved in toxic shock.
    Billiau A
    Nature; 1988 Feb; 331(6158):665. PubMed ID: 3344042
    [No Abstract]   [Full Text] [Related]  

  • 10. [New perspectives in immunotherapy: adhesion molecules, superantigens, heat-shock proteins and cytokine antagonists].
    Gause A; Sahin U; Pfreundschuh M
    Dtsch Med Wochenschr; 1992 Nov; 117(46):1764-73. PubMed ID: 1425297
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monoclonal antibodies in the treatment of sepsis and septic shock].
    Torrabadella de Reynoso P; Salgado Remigio A; Peracaula Picart R
    Med Clin (Barc); 1992 Dec; 99(20):784-92. PubMed ID: 1460952
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunotherapy in rheumatoid arthritis; current status].
    Breedveld FC; van de Putte LB
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1255-9. PubMed ID: 8700279
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytokines and antagonists in septic shock].
    Girardin E; Dayer JM
    Schweiz Med Wochenschr; 1993 Mar; 123(11):480-91. PubMed ID: 8386392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of sepsis syndrome: a comparison of the available treatments.
    Fisher CJ; Bellingan G
    Klin Wochenschr; 1991; 69 Suppl 26():162-7. PubMed ID: 1813714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sepsis syndrome: progress and therapeutic perspectives].
    Schaller MD
    Schweiz Med Wochenschr; 1992 May; 122(20):768-75. PubMed ID: 1604283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis].
    van Deventer SJ; van der Linden CJ; Roord JJ; Schellekens H; Schellekens JF
    Ned Tijdschr Geneeskd; 1993 Feb; 137(7):334-6. PubMed ID: 8437630
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy in the management of sepsis.
    Sikora JP
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):317-24. PubMed ID: 12455865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock.
    Beutler B
    New Horiz; 1993 Feb; 1(1):3-12. PubMed ID: 7922391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targets for sepsis therapies: tumor necrosis factor versus interleukin-1.
    Russell DA; Thompson RC
    Curr Opin Biotechnol; 1993 Dec; 4(6):714-21. PubMed ID: 7764470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of septic shock with antibodies to tumour necrosis factor.
    Cohen J; Exley AR
    Schweiz Med Wochenschr; 1993 Mar; 123(11):492-6. PubMed ID: 8475356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.